Pharmacoeconomics and outcomes research degree-granting PhD programs in the United States

BackgroundEvidence is missing on showcasing current practices of degree programs specific to the field of pharmaceutical outcomes research.ObjectivesTo measure current practices of pharmacoeconomics and outcomes research PhD programs in the United States and synthesize recommendations for improving the success of programs and prospective students.MethodsA 23-question online survey instrument was created and distributed to 32 program directors identified in the International Society for Pharmacoeconomics and Outcomes Research educational directory. Descriptive statistics summarized both the program characteristics (including observed and desired number of faculty and students) and training recommendations (traits of program and student success).ResultsOf 30 eligible programs that conferred a PhD in pharmacoeconomics, pharmaceutical outcomes research, or a related field, 16 respondents (53%) completed the survey. Seventy-five percent of respondents were located in a school of pharmacy. The average observed number of faculty (7.5) and students (11.5) was lower than the average desired numbers (8.1) and (14.7), respectively. Reputation of faculty research and a collaborative environment with other disciplines were rated highest for a program’s success. Faculty’s mentoring experience and reputation and student funding opportunities were rated highest for prospective students’ success.ConclusionsExisting and emerging programs as well as prospective students can use these findings to further their chances of success.